Quality and quantity in hepatopathology. Diagnostic and clinically relevant grading for non-tumourous liver diseases;Maß und zahl in der hepatopathologie. Diagnostisch und klinisch relevante graduierungen bei nichttumorösen lebererkrankungen

Pathologe

Volumn 29, Issue 1, 2008, Pages 15-26

  Longerich, T ^a   Flechtenmacher, C ^a   Schirmacher, P ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Grading; Liver biopsy; Prognosis; Scoring systems; Staging

Indexed keywords

ARTICLE; AUTOIMMUNE HEPATITIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FATTY LIVER; HEMOSIDEROSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER DISEASE; LIVER TOXICITY; SCORING SYSTEM; CLASSIFICATION; DRUG EFFECT; FEMALE; LIVER; LIVER TRANSPLANTATION; MALE; NECROSIS; PATHOLOGY; REVIEW;

METHOTREXATE;

FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; METHOTREXATE; NECROSIS;

EID: 39149115058     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-007-0963-1     Document Type: Article

References (52)

1. Alla V, Bonkovsky HL (2005) Iron in nonhemochromatotic liver disorders. Semin Liver Dis 25: 461-472
2. Alvarez F, Berg PA, Bianchi FB et al. (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: C929-938
3. Angulo P, Larson DR, Therneau TM et al. (1999) Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 94: 3310-3313
4. Arima M, Terao H, Kashima K et al. (2004) Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis. Intern Med 43: 902-910
5. Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19: 1409-1417
6. Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38: 1449-1457
7. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293
8. Blumberg RS, Chopra S, Ibrahim R et al. (1988) Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology 95: 1399-1402
9. Brunt EM, Janney CG, Di Bisceglie AM et al. (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474
10. Chevallier M, Guerret S, Chossegros P et al. (1994) A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 20: 349-355
11. Czaja AJ, Carpenter HA (2001) Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 34: 659-665
12. Czaja AJ, Carpenter HA (1993) Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 105: 1824-1832
13. Czaja AJ, Davis GL, Ludwig J et al. (1984) Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology 4: 622-627
14. Demetris A, Adams D, Bellamy C et al. (2000) Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 31: 792-799
15. Desmet VJ, Gerber M, Hoofnagle JH et al. (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520
16. Deugnier YM, Turlin B, Powell LW et al. (1993) Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 17: 30-34
17. Diehl AM, Goodman Z, Ishak KG (1988) Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95: 1056-1062
18. Edmondson HA, Peters RL, Reynolds TB et al. (1963) Sclerosing hyaline necrosis of the liver in the chronic alcoholic. A recognizable clinical syndrome. Ann Intern Med 59: 646-673
19. Falize L, Guillygomarc'h A, Perrin M et al. (2006) Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 44: 472-477
20. Fellows IW, Stewart M, Jeffcoate WJ et al. (1988) Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis. Gut 29: 1603-1606
21. Goh J, Callagy G, McEntee G et al. (1999) Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature. Eur J Gastroenterol Hepatol 11: 915-919
22. Goldin RD, Goldin JG, Burt AD et al. (1996) Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 25: 649-654
23. Gressner AM (1991) Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem 29: 293-311
24. Hiramatsu K, Aoyama H, Zen Y et al. (2006) Proposal of a new staging and grading system of the liver for primary biliary cirrhosis. Histopathology 49: 466-478
25. International Panel (1997) Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25: 658-663
26. Ishak K, Baptista A, Bianchi L et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699
27. Ishak KG, Zimmerman HJ (1995) Morphologic spectrum of drug-induced hepatic disease. Gastroenterol Clin North Am 24: 759-786
28. Johnson PJ, McFarlane IG (1993) Meeting report: International Autoimmune Hepatitis Group. Hepatology 18: 998-1005
29. Kaji K, Nakanuma Y, Sasaki M et al. (1995) Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C. Hum Pathol 26: 1080-1085
30. Kleiner DE, Brunt EM, Van Natta M et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321
31. Knodell RG, Ishak KG, Black WC et al. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-435
32. Locke GR 3rd, Therneau TM, Ludwig J et al. (1996) Time course of histological progression in primary biliary cirrhosis. Hepatology 23: 52-56
33. Ludwig J, Dickson ER, McDonald GS (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379: 103-112
34. Ludwig J, Wiesner RH, Batts KP et al. (1987) The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 7: 476-483
35. Marcellin P, Asselah T, Boyer N (2002) Fibrosis and disease progression in hepatitis C. Hepatology 36: S47-56
36. Masseroli M, Caballero T, O'Valle F et al. (2000) Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 32: 453-464
37. Matteoni CA, Younossi ZM, Gramlich T et al. (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413-1419
38. Neil DA, Hubscher SG (2002) Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. Hepatology 35: 639-651
39. Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219
40. Nyfors A, Poulsen H (1977) Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis. Am J Surg Pathol 1: 235-243
41. Roenigk HH Jr., Auerbach R, Maibach HI et al. (1982) Methotrexate guidelines - revised. J Am Acad Dermatol 6: 145-155
42. Roenigk HH Jr., Auerbach R, Maibach HI et al. (1988) Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol 19: 145-156
43. Roenigk HH Jr., Bergfeld WF, St Jacques R et al. (1971) Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol 103: 250-261
44. Rubin E, Schaffner F, Popper H (1965) Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis. Am J Pathol 46: 387-407
45. Rubio CA, Porwit A (1988) Quantitation of fibrosis in liver biopsies. Anal Quant Cytol Histol 10: 107-109
46. Scheuer P (1967) Primary biliary cirrhosis. Proc R Soc Med 60: 1257-1260
47. Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372-374
48. Scheuer PJ, Williams R, Muir AR (1962) Hepatic pathology in relatives of patients with haemochromatosis. The Journal Pathol Bacteriol 84: 53-64
49. Schirmacher P, Fleig WE, Tannapfel A et al. (2004) Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet). Pathologe 25: 337-348
50. Sebagh M, Blakolmer K, Falissard B et al. (2002) Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema. Hepatology 35: 117-125
51. Sebagh M, Debette M, Samuel D et al. (1999).,Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection. Hepatology 30: 1144-1150
52. Singh R, Nair S, Farr G et al. (2002) Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature. Am J Gastroenterol 97: 2670-2673